Overview

A Pilot Study of Sildenafil in COVID-19

Status:
Recruiting
Trial end date:
2020-11-09
Target enrollment:
Participant gender:
Summary
Observe the efficacy and safety of G1(Sildenafil citrate tablets) in patients with COVID-19 under clinical actual diagnosis and treatment conditions
Phase:
Phase 3
Details
Lead Sponsor:
Tongji Hospital
Treatments:
Citric Acid
Sildenafil Citrate
Sodium Citrate